Mechanism of protection induced by group A Streptococcus vaccine candidate J8-DT: Contribution of B and T-cells towards protection

PLoS ONE

Volumn 4, Issue 4, 2009, Pages

  Pandey, Manisha ^a   Batzloff, Michael R ^a   Good, Michael F ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA TOXOID; GLUTAMINYLALANYLGLUTAMYLASPARTYLLYSYLVALYLLYSYLGLUTAMINYLSERYLARGINYLGLUTAMYLALANYLLYSYLLYSYLGLUTAMINYLVALYLGLUTAMYLLYSYLALANYLLYSYLGLUTAMINYLLEUCYLGLUTAMYLASPARTYLLYSYLVALYLGLUTAMINYLCYSTEINE; PEPTIDE VACCINE; STREPTOCOCCUS VACCINE; UNCLASSIFIED DRUG; BACTERIAL VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; GROUP A STREPTOCOCCAL INFECTION; HELPER CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFECTION PREVENTION; INFECTION RESISTANCE; LEUKOCYTE FUNCTION; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; SCID MOUSE; T CELL DEPLETION; T LYMPHOCYTE; AMINO ACID SEQUENCE; ANIMAL; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; LYMPHOCYTE DEPLETION; MOLECULAR GENETICS; MOUSE MUTANT; STREPTOCOCCUS PYOGENES;

BACTERIA (MICROORGANISMS); MUS; ORYCTOLAGUS CUNICULUS; STREPTOCOCCUS SP. 'GROUP A';

AMINO ACID SEQUENCE; ANIMALS; B-LYMPHOCYTES; BACTERIAL VACCINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; LYMPHOCYTE DEPLETION; MICE; MICE, SCID; MOLECULAR SEQUENCE DATA; STREPTOCOCCUS PYOGENES; T-LYMPHOCYTES;

EID: 64549134250     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005147     Document Type: Article

References (23)

1. Relf WA, Cooper J, Brandt ER, Hayman WA, Anders RF, et al. (1996) Mapping a conserved conformational epitope from the M protein of group A streptococci. Pept Res 9: 12-20.
2. Hayman WA, Brandt ER, Relf WA, Cooper J, Saul A, et al. (1997) Mapping the minimal murine T cell and B cell epitopes within a peptide vaccine candidate from the conserved region of the M protein of group A streptococcus. Int Immunol 9: 1723-1733.
3. Batzloff MR, Hayman WA, Davies MR, Zeng M, Pruksakorn S, et al. (2003) Protection against group A streptococcus by immunization with J8-diphtheria toxoid: contribution of J8- and diphtheria toxoid-specific antibodies to protection. J Infect Dis 187: 1598-1608.
4. Gupta M, Mahanty S, Bray M, Ahmed R, Rollin PE (2001) Passive transfer of antibodies protects immunocompetent and immunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication. Journal of Virology 75: 4649-4654.
5. Beedham RJ, Turnbull PCB, Williamson ED (2001) Passive transfer of protection against Bacillus anthracis infection in a murine model. Vaccine 19: 4409-4416.
6. Kennedy BJ, Novotny LA, Jurcisek JA, Lobet Y, Bakaletz LO (2000) Passive transfer of antiserum specific for immunogens derived from a nontypeable Haemophilus influenzae adhesin and lipoprotein D prevents otitis media after heterologous challenge. Infection and Immunity 68: 2756-2765.
7. Smith DJ, King WF, Godiska R (2001) Passive transfer of immunoglobulin Y antibody to Streptococcus mutans glucan binding protein B can confer protection against experimental dental caries. Infection and Immunity 69: 3135-3142.
8. Liu MY, Zhu H, Zhang JL, Lei BF (2007) Active and passive immunizations with the streptococcal esterase Sse protect mice against subcutaneous infection with group A Streptococci. Infection and Immunity 75: 3651-3657.
9. Sriskandan S, Ferguson M, Elliot V, Faulkner L, Cohen J (2006) Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation. Journal of Antimicrobial Chemotherapy 58: 117-124.
10. Darenberg J, Soderquist B, Normark BH, Norrby-Teglund A (2004) Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: Implications for therapy of toxic shock syndrome. Clinical Infectious Diseases 38: 836-842.
11. Houghten RA (1985) General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. Proc Natl Acad Sci U S A 82: 5131-5135.
12. Coligan JE, Kruisbeek AM, Margulie DH, Shevach EM, Strober W Current protocols in immunology. New York: John Wiley.
13. Pandey M, Batzloff M, Good M (2006) Investigation of the factors affecting catabolism of antibodies raised againstt a vaccine candidate based on the conserved region of the M-protein. International Congress Series 1289: 336-339.
14. Bjorkholm B, Bottiger M, Christenson B, Hagberg L (1986) Antitoxin Antibody-Levels and the Outcome of Illness During an Outbreak of Diphtheria among Alcoholics. Scandinavian Journal of Infectious Diseases 18: 235-239.
15. Rhinehartjones TR, Fortier AH, Elkins KL (1994) Transfer of Immunity against Lethal Murine Francisella Infection by Specific Antibody Depends on Host Gamma-Interferon and T-Cells. Infection and Immunity 62: 3129-3137.
16. Li JSY, Winslow GM (2003) Survival, replication, and antibody susceptibility of Ehrlichia chaffeensis outside of host cells. Infection and Immunity 71: 4229-4237.
17. Ohashi N, Zhi N, Zhang YL, Rikihisa Y (1998) Immunodominant major outer membrane proteins of Ehrlichia chaffeensis are encoded by a polymorphic multigene family. Infection and Immunity 66: 132-139.
18. Winslow GM, Yager E, Shilo K, Volk E, Reilly A, et al. (2000) Antibody-mediated elimination of the obligate intracellular bacterial pathogen Ehrlichia chaffeensis during active infection. Infection and Immunity 68: 2187-2195.
19. Siegert J, Sastalla I, Chhatwal GS, Medina E (2006) Vaccination equally enables both genetically susceptible and resistant mice to control infection with group A streptococci. Microbes and Infection 8: 347-353.
20. Kar S, Metz C, McMahon-Pratt D (2005) CD4(+) T cells play a dominant role in protection against new world leishmaniasis induced by vaccination with the p-4 amastigote antigen. Infection and Immunity 73: 3823-3827.
21. Hemachudha T, Mitrabhakdi E, Wilde H, Vejabhuti A, Siripataravanit S, et al. (1999) Additional reports of failure to respond to treatment after rabies exposure in Thailand. Clinical Infectious Diseases 28: 143-144.
22. Plotkin SA (2000) Rabies. Clinical Infectious Diseases 30: 4-12.
23. Hirunpetcharat C, Vukovic P, Xue QL, Kaslow DC, Miller LH, et al. (1999) Absolute requirement for an active immune response involving B cells and Th cells in immunity to Plasmodium yoelii passively acquired with antibodies to the 19-kDa carboxyl-terminal fragment of merozoite surface protein-1. Journal of Immunology 162: 7309-7314.